{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:40:22Z","timestamp":1784947222563,"version":"3.55.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Maternal-Fetal & Neonatal Medicine"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1080\/jmf.12.4.267.273","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T12:37:56Z","timestamp":1260189476000},"page":"267-273","source":"Crossref","is-referenced-by-count":30,"title":["Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome"],"prefix":"10.1080","volume":"12","author":[{"given":"T.","family":"Agorastos","sequence":"first","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Karavida","sequence":"additional","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lambropoulos","sequence":"additional","affiliation":[{"name":"Department of General and Molecular Biology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Constantinidis","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Democritus University of Thrace, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tzitzimikas","sequence":"additional","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chrisafi","sequence":"additional","affiliation":[{"name":"Department of General and Molecular Biology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Saravelos","sequence":"additional","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vavilis","sequence":"additional","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kotsis","sequence":"additional","affiliation":[{"name":"Department of General and Molecular Biology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bontis","sequence":"additional","affiliation":[{"name":"First University Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-9-199905040-00013"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/14767059809020459"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.882901.x"},{"key":"e_1_2_1_5_1","first-page":"1004","article-title":"Svensson PJ","volume":"90","author":"Dahlback B","year":"1993","unstructured":"Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated proteinC. Proc Natl Acad Sci USA 1993;90:1004\u20138","journal-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated proteinC. Proc Natl Acad Sci USA"},{"key":"e_1_2_1_6_1","first-page":"64","article-title":"Koster T, et al","volume":"369","author":"Bertina RM","year":"1994","unstructured":"Bertina RM, KoelemanBPC, Koster T, et al.Mutationinblood coagulation factor V associated with resistance to activated protein C. Nature (London) 1994;369:64\u20137","journal-title":"Mutationinblood coagulation factor V associated with resistance to activated protein C. Nature (London)"},{"key":"e_1_2_1_7_1","first-page":"1133","article-title":"Clegg JB","volume":"364","author":"Rees DC","year":"1995","unstructured":"Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;364:1133\u20134","journal-title":"World distribution of factor V Leiden. Lancet"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"LambropoulosAF Foka Z MakrisM et al. FactorV Leiden in Greek thrombophilic patients: relationship with activated proteinCresistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2. Blood Coagul Fibrinolysis 1997;8: 485\u20139","DOI":"10.1097\/00001721-199711000-00001"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Poort SR Rosendaal FR Reitsma PH et al.Acommon genetic variation in the 3\ufffd untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88: 3698\u2013703","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615049"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","article-title":"Factor V Cambridge: a new mutation (Arg 306 Thr) associated with resistance to activated protein C","volume":"91","author":"Williamson D","year":"1998","unstructured":"Williamson D, Brown K, Ludington R, et al. Factor V Cambridge: a new mutation (Arg 306 Thr) associated with resistance to activated protein C. Blood 1998;91:1140\u20134","journal-title":"Blood"},{"key":"e_1_2_1_12_1","author":"American College of Obstetricians and Gynecologists","year":"1996","unstructured":"American College of Obstetricians and Gynecologists.Hypertension in Pregnancy. Technical Bulletin no. 219.Washington, DC: American College of Obstetricians and Gynecologists, 1996","journal-title":"Hypertension in Pregnancy. Technical Bulletin no. 219.Washington"},{"key":"e_1_2_1_13_1","first-page":"510","author":"Bennedetti TJ","year":"2002","unstructured":"Bennedetti TJ. Obstetric haemorrage. In Gabbe S, ed. Obstetrics - Normal and Problem Pregnancies, 4th edn. New York: Churchill Livingstone, 2002:510","journal-title":"Obstetric haemorrage"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901073400102"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70025-0"},{"key":"e_1_2_1_16_1","first-page":"555","article-title":"HendricksCH","volume":"126","author":"Brenner WE","year":"1976","unstructured":"Brenner WE, Edelman DA, HendricksCH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555\u201364","journal-title":"A standard of fetal growth for the United States of America. Am J Obstet Gynecol"},{"key":"e_1_2_1_17_1","unstructured":"Bernstein I Gabbe S Reed K. Intrauterine growth restriction. In Gabbe S ed. Obstetrics - Normal and Problem Pregnancies 4th edn. New York: Churchill Livingstone 2002:870\u20131"},{"key":"e_1_2_1_18_1","unstructured":"Han VK. Fetal growth and its regulation. In Rodeck CH Whittle MJ eds. Fetal Medicine. London: Churchill Livingstone 1999:136\u20137"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016340009169243"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002103420602"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0037-1614222","article-title":"Factor VQ506 mutation (APC resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism","volume":"79","author":"Lindqvist PG","year":"1998","unstructured":"Lindqvist PG, Svenson PJ, Dahlback B, et al. Factor VQ506 mutation (APC resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism. Thromb Haemost 1998;79:69\u201373","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91324-6"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9378(97)70515-5","article-title":"Preeclampsia is associatedwith a reduced response to activatedproteinC","volume":"176","author":"Lindoff C","year":"1997","unstructured":"Lindoff C, Ingemarsson I, Martinsson G, et al. Preeclampsia is associatedwith a reduced response to activatedproteinC. Am J Obstet Gynecol 1997;176:457\u201360","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_24_1","first-page":"902","article-title":"al","volume":"175","author":"Dizon-Townson DS","year":"1996","unstructured":"Dizon-Townson DS, NelsonLM, Easton K, et al. The factorV Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902\u20135","journal-title":"The factorV Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol"},{"key":"e_1_2_1_25_1","first-page":"457","article-title":"Activated protein C resistance and factor V Leiden in patients with hemolysis, elevatedliver enzymes, low platelets syndrome","volume":"92","author":"Kraus T","year":"1998","unstructured":"Kraus T, Augustin GA, Osmers R, et al. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevatedliver enzymes, low platelets syndrome.ObstetGynecol 1998;92:457\u201360","journal-title":"ObstetGynecol"},{"key":"e_1_2_1_26_1","first-page":"45","article-title":"Severe preeclampsia and high frequency of genetic thrombophilic mutations","volume":"96","author":"Kupferminc MJ","year":"2000","unstructured":"Kupferminc MJ, Fait G, Many A, et al. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000;96:45\u20139","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case- control study","volume":"181","author":"De Groot CJM, Bloemenkamp KWM, Duvecot EJ, et al.","year":"1999","unstructured":"De Groot CJM, Bloemenkamp KWM, Duvecot EJ, et al. Preeclampsia and genetic risk factors for thrombosis: a case- control study. Am J Obstet Gynecol 1999;181:975\u201380","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_28_1","first-page":"753","article-title":"Postnatal screening for thrombophilia in women with severe pregnancy complications","volume":"97","author":"Alfirevic Z","year":"2001","unstructured":"Alfirevic Z, Mousa HA, Martlew V, et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001;97:753\u20139","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614519"},{"key":"e_1_2_1_30_1","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck CJ","year":"2001","unstructured":"Glueck CJ, Kupferminc MJ, Fontaine RN, et al. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44\u20138","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994947"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Kingdom J Baker P. Intrauterine Growth Restriction: Aetiology and Management. London: Springer-Verlag 2000:260","DOI":"10.1007\/978-1-4471-0735-4"},{"key":"e_1_2_1_33_1","first-page":"913","article-title":"FR,Walker ID, et al","volume":"348","author":"Preston FE","year":"1996","unstructured":"Preston FE, Rosendaal FR,Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348: 913\u201316","journal-title":"Increased fetal loss in women with heritable thrombophilia. Lancet"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614594"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614620"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010053431405"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.2.458"}],"container-title":["The Journal of Maternal-Fetal & Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/jmf.12.4.267.273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:23:01Z","timestamp":1770416581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/jmf.12.4.267.273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1080\/jmf.12.4.267.273"],"URL":"https:\/\/doi.org\/10.1080\/jmf.12.4.267.273","relation":{},"ISSN":["1476-7058","1476-4954"],"issn-type":[{"value":"1476-7058","type":"print"},{"value":"1476-4954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}